Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of lipid microsphere composition

A technology of lipid microspheres and compositions, applied in the direction of non-active ingredients of oil/fat/wax, medical preparations of non-active ingredients, antibody medical ingredients, etc., can solve problems such as difficulty in increasing vaccine supply

Active Publication Date: 2011-12-28
LIAONING CHENGDA BIOTECH
View PDF8 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0026] Influenza vaccines are needed in large quantities during flu outbreaks, but it is difficult to increase vaccine supply to meet such a huge demand

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of lipid microsphere composition
  • A kind of lipid microsphere composition
  • A kind of lipid microsphere composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0177] Preparation of Lipid Microsphere Emulsion Adjuvant

[0178] (1) Weigh 20g of soybean oil, 50g of medium-chain oil, 18g of soybean lecithin, and 0.1g of vitamin E, heat and stir in a water bath to mix evenly, and keep the temperature at 70°C as the oil phase; (2) weigh polysorbate 80 (Tween80 ) 2g was added to an appropriate amount of water for injection, heated and stirred to dissolve it, and kept at a temperature of 70°C as the water phase.

[0179] Mix the two phases of oil and water under stirring, and continue to stir to form colostrum; (3) the volume of colostrum is adjusted to 1000mL with water for injection, homogenized by 750bar high-pressure milk for 6 times, and the pH is adjusted to 7.5 with sodium hydroxide to obtain fat A microsphere emulsion type adjuvant.

Embodiment 2

[0181] Preparation of Lipid Microsphere Emulsion Adjuvant

[0182] (1) Weigh 60 g of medium-chain oil, 10 g of soybean lecithin, 3 g of hydrogenated lysophospholipid, and 0.5 g of oleic acid, heat and stir in a water bath to mix evenly, and keep the temperature at 75 ° C to form the oil phase; (2) weigh poloxamer 1881.5 g, 2.25 g of glycerol was added into the citrate buffer solution with a pH of 7.8, heated and stirred to dissolve, and the temperature was maintained at 75° C. as the water phase.

[0183] Mix the two phases of oil and water under stirring, and continue to stir to form colostrum; (3) the colostrum is adjusted to 1000mL with buffer solution, and the lipid microsphere emulsion type adjuvant can be obtained by 800bar high-pressure emulsion for 4 times.

Embodiment 3

[0185] Preparation of Lipid Microsphere Emulsion Adjuvant

[0186] (1) Weigh 60g of peanut oil and 15g of egg yolk phospholipid, heat and stir in a water bath until the phospholipid dissolves, and keep the temperature at 70°C as the oil phase; (2) Weigh 5.0g of sodium deoxycholate and add it to an appropriate amount of water for injection, heat Stir to dissolve and keep the temperature at 70°C as the water phase. Mix the two phases of oil and water under stirring, and continue to stir to form colostrum; (3) The volume of colostrum is adjusted to 1000mL with water for injection, homogenized by 1000bar high-pressure emulsification for 5 times, and the pH is adjusted to 7.0 with sodium bicarbonate. The lipid microsphere emulsion type adjuvant can be obtained.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
The average particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention relates to a lipid microsphere composition. The lipid microsphere composition is characterized by comprising a lipid microsphere emulsifying agent and an immunogenic composition, wherein the lipid microsphere emulsifying agent comprises 1 to 30 weight percent of pharmaceutical grade grease, 0.1 to 10 weight percent of zwitterionic / non-ionic surfactant composition, 0.01 to 5 weight percent of stabilizing agent and the balance of aqueous solution; and the immunogenic composition is a univalent to multivalent composition and usually a trivalent composition, and contains a virus antigen or antigenic preparation from one or more pandemic influenza epidemic related influenza virus strains or with one or more pandemic influenza epidemic related influenza virus strains. The lipid microsphere composition not only can serve as an excellent aid of a vaccine, but also can serve as a conveying system of the vaccine. The lipid microsphere composition is applicable to different administration routes of the vaccine, improves compliance, diversity and selectivity of clinical application, and achieves wide, safe and effective immune effect.

Description

technical field [0001] The present invention relates to a biological product, in particular to a lipid microsphere composition containing a vaccine that can be safely used in humans or other animals. As a novel vaccine adjuvant and delivery system, it is particularly important that the present invention The lipid microsphere composition can well enhance the immune response of the human body to various antigens, has an excellent immune regulation function so as to achieve the effect of cross protection, and belongs to the technical field of biomedicine. Background technique [0002] The vaccine currently used in the European version of the pandemic H1N1 flu vaccine can completely alter the body's immune response to the flu vaccine and enhance The body's ability to produce an antibody response to many types of flu. [0003] Adjuvants are substances that people often add to vaccines to boost the immune response, but are ineffective on their own; the exact reason for this pheno...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/107A61K39/39A61K39/145A61K39/295A61K47/44A61K47/34A61K47/28A61K47/24A61P31/16
Inventor 高军李淑斌段鹏杰魏晓莹周荔葆殷建文万艾玲
Owner LIAONING CHENGDA BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com